G protein-coupled receptor kinase 2
G protein-coupled receptor kinase 2
G protein-coupled receptor kinase 2 (GRK2), also known as beta-adrenergic receptor kinase 1 (βARK1), is a protein encoded by the ADRBK1 gene in humans. GRK2 is a member of the G protein-coupled receptor kinase family and plays a crucial role in the regulation of G protein-coupled receptors (GPCRs).
Structure
GRK2 consists of several domains, including an N-terminal domain, a central catalytic domain, and a C-terminal domain. The N-terminal domain is responsible for membrane localization, while the catalytic domain is involved in phosphorylating GPCRs upon activation. The C-terminal domain plays a role in regulating GRK2 activity and interactions with other proteins.
Function
GRK2 functions as a key regulator of GPCR signaling by phosphorylating activated GPCRs. This phosphorylation leads to the desensitization and internalization of GPCRs, thereby attenuating downstream signaling pathways. GRK2 is particularly known for its role in regulating beta-adrenergic receptors, which are involved in various physiological processes such as heart rate regulation and smooth muscle contraction.
Regulation
The activity of GRK2 is tightly regulated by various mechanisms, including phosphorylation, protein-protein interactions, and subcellular localization. Phosphorylation of GRK2 can modulate its kinase activity and substrate specificity. Additionally, interactions with other proteins, such as GPCRs and arrestins, can influence the localization and activity of GRK2.
Clinical significance
Dysregulation of GRK2 has been implicated in various diseases, including heart failure, hypertension, and diabetes. Alterations in GRK2 expression or activity can disrupt GPCR signaling pathways, leading to pathological conditions. Targeting GRK2 has emerged as a potential therapeutic strategy for treating GPCR-related disorders.
See also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD